Clinical Trials Browser

Active not recruiting × Urothelial Cancer × enfortumab vedotin × Clear all

NCT04223856 2025-06-13

EV-302

Phase 3 Active not recruiting

886 enrolled 12 charts 1 FDA

Urothelial Cancer